Brady Johnson - Dec 29, 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Signature
/s/ Brady Johnson
Stock symbol
CDTX
Transactions as of
Dec 29, 2021
Transactions value $
-$520
Form type
4
Date filed
1/7/2022, 07:23 PM
Previous filing
Oct 5, 2021
Next filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Options Exercise $0 +262 +0.51% $0.00 51.4K Dec 29, 2021 Direct F1, F2
transaction CDTX Common Stock Sale -$520 -416 -0.81% $1.25 51K Jan 5, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Restricted Stock Unit Options Exercise $0 -262 -50% $0.00 262 Dec 29, 2021 Common Stock 262 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
F3 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F4 Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F5 On January 31, 2019, the Reporting Person was granted RSUs totaling 787 shares subject to vesting upon the achievement of various milestones.